Piramal Pharma Limited Cash Flow Quality Index
Piramal Pharma Limited cash flow quality index. Piramal Pharma Limited (PPLPHARMA) has a Cash Flow Quality Index of 36.86x as of December 2023. Operating cash flow of Rs3.73 Billion exceeds net income of Rs101.10 Million, indicating high earnings quality where cash backs reported profits. Explore how well can Piramal Pharma Limited service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Piramal Pharma Limited (2021–2025)
Cash flow quality index of Piramal Pharma Limited from 2021 to 2025. Historical Cash Flow Quality Index for Piramal Pharma Limited across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. See how leveraged is Piramal Pharma Limited's balance sheet to measure how much of total assets are equity-financed.
Piramal Pharma Limited Cash Flow Quality Index by Year (2021–2025)
Piramal Pharma Limited cash flow quality index by year from 2021 to 2025. Year-by-year earnings quality comparison for Piramal Pharma Limited. For the full cash flow conversion analysis, see PPLPHARMA cash flow conversion.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 9.79x | Rs8.92 Billion | Rs911.30 Million | ▼ -82.6% |
| 2024 | 56.37x | Rs10.05 Billion | Rs178.20 Million | ▲ +9546.3% |
| 2022 | 0.58x | Rs2.55 Billion | Rs4.37 Billion | ▲ +487.6% |
| 2021 | 0.10x | Rs347.20 Million | Rs3.49 Billion | — |